Has Nikky Bardia received payments from drug or device companies?

Yes. Drug and device makers reported $9,225 in general payments to Nikky Bardia across 168 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nikky Bardia did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nikky Bardia come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nikky Bardia

Cardiovascular Disease · Bakersfield, CANPI 1932559978

Payments from drug & device makers

$9,225in general payments, 2019–2025

Across 168 payments — averaging $54.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$3K
Boston Scientific$2K
Medtronic$715
Abbott$553
Cardiva Medical, Inc.$356
Penumbra, Inc.$315
plus $2K from 25 others

What the payments were for

Grants$1,06312%
Travel & lodging$2,33425%
Food & beverage$5,13956%
Education$6897%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	53	$2,931
Boston Scientific	17	$1,918
Medtronic	9	$715
Abbott	14	$553
Cardiva Medical, Inc.	9	$356
Penumbra, Inc.	3	$315
Novo Nordisk	4	$267
Stryker	2	$261
Amgen	4	$222
Abiomed	6	$177
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	6	$171
Chiesi USA, Inc.	4	$157
Heartflow, Inc.	2	$156
Novartis	8	$151
Boehringer Ingelheim	2	$125
Shockwave Medical, Inc	2	$124
Cordis US CORP.	3	$118
W. L. Gore & Associates, Inc.	2	$71
Inari Medical, Inc.	2	$55
E.r. Squibb & Sons, L.L.C.	3	$54
AstraZeneca(2 entities)	2	$50
Johnson & Johnson	2	$44
Terumo Medical Corporation	1	$38
Angiodynamics, Inc.	1	$35
Lexicon Pharmaceuticals, Inc.	1	$32
Imperative Care, Inc	1	$31
Kestra Medical Technology Services, Inc.	1	$24
Sanofi	1	$24
Alnylam Pharmaceuticals Inc.	1	$23
Teleflex LLC	1	$16
Pfizer	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,225 in reported general payments places this provider in the 70th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	14	$196

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Bakersfield

Ted LoveHillsborough$102.8M
Matthew BudoffTorrance$11.3M
Lori DanielsSan Diego$10.2M
Paul KurthSanta Barbara$6.1M
Michael BlumSan Francisco$5.5M
Tony ChouSan Francisco$5.2M
Jason RogersSacramento$5.1M
Yu-Ping WangStanford$3.8M
Yogesh PaliwalPomona$3.3M
Farhad RafiiWest Hills$3.2M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →